Literature DB >> 140943

Multicellular spheroids: a new model target for in vitro studies of immunity to solid tumor allografts.

R M Sutherland, H R MacDonald, R L Howell.   

Abstract

Multicellular spheroids of EMT6 mammary sarcoma cells of BALB/c origin were incubated with normal spleen cells or alloimmune spleen cells generated in vitro in mixed leukocyte cultures (MLC). After 24 hours, spheroids were trypsinized and assayed for surviving tumor cells by use of a cloning technique. Under these conditions a 60-80% reduction in clone-forming tumor cells was observed after incubation of spheroids with immune lymphocytes as compared to normal lymphocyte controls. This cytotoxic effect occurred in situ, and alloimmune cells sensitized against unrelated antigens were much less cytotoxic than were specifically sensitized cells. In parallel autoradiographic studies, some immune lymphoid cells that had been labeled with tritiated thymidine during the proliferative phase of the MLC could be demonstrated within spheroids after 24 hours. These results suggested that multicellular spheroids will be a useful in vitro model for more detailed analysis of the factors controlling infiltration in in situ destruction of solid tumor grafts.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 140943     DOI: 10.1093/jnci/58.6.1849

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  17 in total

1.  Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers.

Authors:  Kathryn M Burleson; Linda K Hansen; Amy P N Skubitz
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

2.  Surface Optimization and Design Adaptation toward Spheroid Formation On-Chip.

Authors:  Neda Azizipour; Rahi Avazpour; Mohamad Sawan; Abdellah Ajji; Derek H Rosenzweig
Journal:  Sensors (Basel)       Date:  2022-04-21       Impact factor: 3.847

Review 3.  Multicellular spheroids. A review on cellular aggregates in cancer research.

Authors:  W Mueller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  A multicellular tumor spheroid model of cellular immunity against head and neck cancer.

Authors:  P G Sacks; D L Taylor; T Racz; T Vasey; V Oke; S P Schantz
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  Approach for chemosensitization of cisplatin-resistant ovarian cancer by cucurbitacin B.

Authors:  Fardous F El-Senduny; Farid A Badria; Ahmed M El-Waseef; Subhash C Chauhan; Fathi Halaweish
Journal:  Tumour Biol       Date:  2015-08-05

6.  Cell aggregate suspension culture for large-scale production of biomolecules.

Authors:  W R Tolbert; M M Hitt; J Feder
Journal:  In Vitro       Date:  1980-06

7.  Association between tumorigenic potential and the fate of cancer cells in a syngeneic melanoma model.

Authors:  Yakov Krelin; Liron Berkovich; Moran Amit; Ziv Gil
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

8.  Down-regulation of DNA mismatch repair enhances initiation and growth of neuroblastoma and brain tumour multicellular spheroids.

Authors:  Samuel L Collins; Rodolphe Hervé; C W Keevil; Jeremy P Blaydes; Jeremy S Webb
Journal:  PLoS One       Date:  2011-12-01       Impact factor: 3.240

Review 9.  Engineered in vitro tumor models for cell-based immunotherapy.

Authors:  Yuta Ando; Chelsea Mariano; Keyue Shen
Journal:  Acta Biomater       Date:  2021-04-20       Impact factor: 10.633

10.  Disaggregation and invasion of ovarian carcinoma ascites spheroids.

Authors:  Kathryn M Burleson; Matthew P Boente; Stefan E Pambuccian; Amy P N Skubitz
Journal:  J Transl Med       Date:  2006-01-24       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.